A groundbreaking new survey is shedding light on how people with eating disorders are turning to alternative ...

The mind-expanding drugs may help heal many mental health conditions. But studies haven’t actually proved that yet.

When it comes to treating stuttering in speech, it may be worthwhile to utilize psychedelic substances, such as psilocybin ...

Mind Medicine has commenced its Phase 3 Voyage study, dosing the first patient with MM120, an optimized form of LSD, for treating Generalized Anxiety Disorder (GAD). This study aims to assess the ...

In early 2022 the FDA cleared an IND, which in turn cleared a clinical hold and allowed the first LSD study in decades. MindMed later engaged in a Phase 2 study involving single doses of 25 mg, 50 ...

A single dose of MM120 100 µg, the dose with optimal clinical activity observed in the study, demonstrated a 7.7-point improvement compared with placebo at week 12 (-21.9 with MM120 vs -14.2 with ...

A psychedelic trip that leaves one person feeling transformed could leave another feeling unsettled — and personality may be ...

A recent study published in Translational Psychiatry sheds new light on the diverse factors that influence how individuals experience the effects of LSD (lysergic acid diethylamide). The research ...

A new study has shed light on the complex changes in brain connectivity induced by LSD, MDMA and d-amphetamine. These compounds share overlapping effects on neurotransmitter systems, influencing ...

Mind Medicine has commenced its Phase 3 Voyage study, dosing the first patient with MM120, an optimized form of LSD, for treating Generalized Anxiety Disorder (GAD).

A new study shows that LSD is highly effective at treating generalized anxiety disorder for up to 12 weeks with just a single dose. And it is fast-acting.